XELODA
CAPECITABINE
Reimbursement base
559,70 MAD
Active substance
CAPECITABINE
Reimbursable
What is this medicine?
Capecitabine is a nucleoside metabolic inhibitor used in the treatment of various malignancies.
Verified summary
CAPECITABINE, COMPRIME PELLICULE, 150 MG, 1 BOITE 60 COMPRIME
Common uses
Treatment of colorectal cancer (including Stage III colon cancer, locally advanced rectal cancer, and unresectable or metastatic colorectal cancer), advanced or metastatic breast cancer, unresectable or metastatic gastric, esophageal, or gastroesophageal junction cancer, and pancreatic adenocarcinoma.
Class
nucleoside metabolic inhibitor
Availability note
Reimbursable
Hospital price
559,70 MAD
Strength
150 MG
Form
COMPRIME PELLICULE
Presentation
1 BOITE 60 COMPRIME
Type
P
Therapeutic class
ANTINEOPLASIQUE CYTOTOXIQUE
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2017-12-18: 0,00 MAD
Available presentations and strengths
Medicines with the same active substance
XELABINE
500 MG · BOITE DE 120
1,78 MAD
CAPECITABINE ACCORD
500 MG · BOITE DE 120
1,95 MAD
CAPECITABINE MYLAN
500 MG · BOITE DE 120
1,95 MAD
DIROGIT
500 MG · BOITE DE 120
1,95 MAD
EPITEA
500 MG · BOITE DE 120
1,95 MAD
XEPINE
500 MG · BOITE DE 120
1,95 MAD
CAPECITABINE ACCORD 500 MG
500 MG · Comprimé pelliculé
1.947,00 MAD
CAPECITABINE MYLAN 500 MG
500 MG · Boite de 20
1.947,00 MAD
CAPECITABINE MYLAN 500 MG
500 MG · Boite de 120
1.947,00 MAD
DIROGITE 500 MG
500 MG · Boite de 120
1.947,00 MAD
XEPINE 500 MG
500 MG · Boite de 120
1.947,00 MAD